Bangladeshi organization claims to have Discovered Corona Vaccine

Globe Biotech Limited, a pharmaceutical company, has claimed to have invented a vaccine against Covid-19 (Coronavirus) for the first time in Bangladesh. The organization says that the vaccine has been successfully applied to animals. Globe Biotech Limited will announce the discovery of the vaccine at a press conference on Thursday. The company said in a press release on Wednesday.

Globe Biotech Ltd. Research and Development Department Head Dr. Asif Mahmood said, “Initially we were successful in corona vaccine. It has been successful at the animal level. Now we hope that our vaccine will work successfully in the human body as well. We will now take the matter to the concerned department of the government. We will then take the next step according to the guidelines given to them.

According to the NCBI virus database, 5,843 complete genome sequences have been submitted worldwide as of Tuesday (June 30), the company said in a statement. Of which 6 have been submitted from Bangladesh. Globe Biotech Limited confirms its ticker target by testing the sequence through the Bioinformatics tool. Which would logically be more effective in this geographical area. The full coding sequence of that target has been submitted to the NCBI virus database in the United States. Which has already been recognized and published by the NCBI?

The chairman of the organization. Harunur Rashid said, "We are working to start a clinical trial to test the safety and effectiveness of this vaccine." We seek the full cooperation of the government in this test.

The epidemic of coronavirus has been going on for six months. Many countries are struggling to cope with the terrible situation of infection and death. In many places, the situation is getting worse day by day. Mortality is also increasing with the increase of infection. In the meantime, many experimental vaccines from different countries are being tested in humans. None have yet been allowed for commercial use. A total of eight vaccines have been approved for human testing in China. The third phase of the vaccine, developed by Oxford and AstraZeneca, is also being tested.